Cost-effectiveness of cardiovascular risk assessment and management among adults with hypertension in China: A modelling study

Cost-effectiveness of cardiovascular risk assessment and management among adults with hypertension in China: A modelling study

Objective: Blood pressure reduction alone is insufficient for significant cardiovascular risk improvement in patients with hypertension. Cardiovascular risk assessment and management are recommended to prevent and control cardiovascular diseases (CVD), but their cost-effectiveness in real-world Chin...

Full description

Saved in:

Bibliographic Details
Main Authors:	Siqi Lin, Liming Lin, Wenyao Peng, Xuan Liu, Xi Li, Jiapeng Lu, Shouling Wu
Format:	Article
Language:	English
Published:	Elsevier 2025-06-01
Series:	American Journal of Preventive Cardiology
Subjects:	Hypertension Cardiovascular risk assessment and management Chinese Cost-effectiveness analysis Statin treatment
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666667725000820
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Influence of the statin therapy on cardiovascular remodeling in arterial hypertension, combined with subclinical hypothyroidism
by: Ye. V. Novikov, et al.
Published: (2020-12-01)

Statins in arterial hypertension treatment
by: O. N. Tkacheva, et al.
Published: (1970-01-01)

Content of matrix metalloproteinases in the blood of hypertensive patients with a high cardiovascular risk receiving statin therapy
by: V. P. Mikhin, et al.
Published: (2022-11-01)

Modifiable factors and 10-year and lifetime cardiovascular disease risk in adults with new-onset hypertension: insights from the Kailuan cohort
by: Shouling Wu, et al.
Published: (2025-02-01)

Pharmacological Profile and Mechanisms of Cardiovascular Protective Effects of Statins: An Update
by: Abdalla Salem Elhwuegi, et al.
Published: (2025-06-01)

Traditional Chinese medicine for cardiovascular disease: efficacy and safety
by: Youwei Lin, et al.
Published: (2024-12-01)

Familial hypercholesterolemia in patients with hypertension: the China H-type Hypertension Registry Study
by: Tianzhou Shen, et al.
Published: (2025-03-01)

ACHIEVEMENT OF LIPID TARGET PLASMA LEVELS IN PATIENTS OF HIGH CARDIOVASCULAR RISK: IS MEDICINE CHOICE IMPORTANT?
by: S. Y. Martsevich, et al.
Published: (2016-01-01)

PRIMARY PREVENTION OF CARDIOVASCULAR COMPLICATIONS: VALUE OF STATINS
by: S. Y. Martsevich, et al.
Published: (2016-01-01)

RHEUMATOID ARTHRITIS AND CARDIOVASCULAR RISK: PERSPECTIVES OF TREATMENT WITH STATINS
by: D. A. Anichkov, et al.
Published: (2015-12-01)

Orthostatic hypertension in cardiovascular risk stratification in hypertensive patients
by: E. Yu. Gubareva, et al.
Published: (2021-04-01)

Primary Preventive Medication Use and Risk of Atherosclerotic Cardiovascular Diseases Among Patients with Hypertension and Diabetes Attending Irrua Specialist Teaching Hospital, Irrua Nigeria
by: Pauline E. Eromon, et al.
Published: (2024-09-01)

UP TO DATE STATINS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES
by: N. F. Puchin'yan, et al.
Published: (2015-12-01)

Association of altitude with all-cause and cardiovascular mortality among patients with hypertension: a cohort study in Southwest China
by: Yu Xia, et al.
Published: (2024-12-01)

Area-level socioeconomic inequalities in hypertension care cascade in China: a nationwide population-based study based on the ChinaHEART projectResearch in context
by: Wenyao Peng, et al.
Published: (2025-04-01)

Frailty, Pitavastatin, and Major Adverse Cardiovascular Events Among People With HIV
by: Kristine M. Erlandson, MD, MS, et al.
Published: (2025-09-01)

Efficacy and safety of statin therapy in multimorbid outpatients with very high cardiovascular risk
by: N. V. Izmozherova, et al.
Published: (2020-07-01)

Statin effects on the lipidome: Predicting statin usage and implications for cardiovascular risk prediction
by: Changyu Yi, et al.
Published: (2025-05-01)

Interactions between gut microbiota and cardiovascular drugs: effects on drug therapeutic effect and side effect
by: Tianyu Wang, et al.
Published: (2025-07-01)

HYPOLIPIDEMIC AND PLEIOTROPIC EFFICACY OF ROSUVASTATIN IN ARTERIAL HYPERTENSION PATIENTS OF HIGH CARDIOVASCULAR RISK IN LONG-TERM OUTPATIENT FOLLOW-UP
by: V. P. Mikhin, et al.
Published: (2016-12-01)

Place of renin-angiotensin-aldosterone system inhibitors and statins in the treatment of cardiovascular patients in the context of COVID-19 pandemic
by: E. V. Sayutina, et al.
Published: (2022-03-01)

The use of statins are associated with an increased risk of new-onset diabetes in patients with hypertension and obstructive sleep apnoea, a longitudinal study
by: Hui Wang, et al.
Published: (2025-04-01)

Statins associated diabetes: state of the problem in 2018
by: Zh. D. Kobalava, et al.
Published: (2018-09-01)

A Randomized Open Clinical Study of the Atherosclerosis Treatment Information Video Effect on Adherence to Long-Term Therapy in Patients with Cardiovascular Diseases
by: Yu. V. Bulaeva, et al.
Published: (2021-11-01)

Cost-effectiveness of evolocumab in treatment of heterozygous familial hypercholesterolaemia in Bulgaria: measuring health benefit by effectively treated patient-years*
by: Borislav Borissov, et al.
Published: (2017-01-01)

Effect of different statins and EZETIMIBE/SIMVASTATIN on cardiovascular disease in patients with chronic kidney disease
by: ZHANG Xue-qing, et al.
Published: (2018-01-01)

CATESTATIN AS A NOVEL MARKER OF CARDIOVASCULAR RISK IN SYSTEMIC HYPERTENSION
by: E. Yu. Gubareva, et al.
Published: (2018-05-01)

NEW POSSIBILITIES OF STATIN THERAPY IN ARTERIAL HYPERTENSION
by: E. M. Khurs, et al.
Published: (2016-01-01)

CARDIOVASCULAR RISK ASSESSMENT IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS WITHIN THE REMARCA STUDY: PRELIMINARY DATA
by: D. S. Novikova, et al.
Published: (2015-03-01)

Optimization of the Statin Therapy Algorithm in Outpatient Practice: Adherence and Economic Benefits
by: S. A. Davitashvili, et al.
Published: (2021-03-01)

Bempedoic Acid for Prevention of Cardiovascular Events in People With Obesity: A CLEAR Outcomes Subset Analysis
by: Harold E. Bays, et al.
Published: (2025-02-01)

The impact of the nocebo effect on discontinuation of statin therapy due to myopathy in patients with cardiovascular disease – a review
by: Jakub Stanek, et al.
Published: (2024-11-01)

The effect of statin therapy on oxidative stress indices in patients with arterial hypertension and type 2 diabetes mellitus
by: V. D. Nemtsova
Published: (2018-02-01)

Assessment of Cardiovascular Risk in Hospitalized Patients with Hypertension Aged 40 and Over
by: Joana Simeonova, et al.
Published: (2017-11-01)

Modifiable risk factors for cardiovascular diseases in women with hypertension
by: Jucian Silva do Nascimento, et al.
Published: (2011-08-01)

Cardiovascular events and additional risk in hypertensive senior citizens
by: Rosimeire Fontes de Queiroz, et al.
Published: (2014-02-01)

Cardiovascular events and additional risk in hypertensive senior citizens
by: Rosimeire Fontes de Queiroz, et al.
Published: (2014-02-01)

Sex-specific associations of the Dietary Inflammatory Index with cardiovascular and non-cardiovascular mortality in hypertensive adults: a cohort study
by: Zhang Youqi, et al.
Published: (2025-06-01)

Comparative effectiveness of statin therapy in patients with hypertension of high and very high cardiovascular risk in actual clinical practice in Irkutsk
by: O. A. Ivanova, et al.
Published: (2021-11-01)

Statin utilization and its predictors for the primary prevention of cardiovascular disease among type 2 diabetic patients in a resource-limited setting
by: Feyisa Assefa Dhaba, et al.
Published: (2025-07-01)